Company intelligence / Profile preview
COMPASS Pathways
London, United Kingdomcompasspathways.com ↗
- Ownership
- Public · CMPS
- Employees
- ~150
- Development stage
- Other
01
Overview
Compass Pathways has completed the largest randomized, controlled, double-blind clinical trial of psilocybin therapy to date. In its phase IIb study for treatment-resistant depression, a single dose of its investigational synthetic psilocybin formulation (COMP360), combined with psychological support, led to statistically significant and clinically meaningful reductions in depressive symptoms at three weeks post-treatment. The antidepressant effect was rapid and durable for up to twelve weeks in some patients. A follow-up observational study showed that these effects could last even longer in certain subgroups. The company has initiated phase III trials for TRD and continues phase II studies in PTSD and anorexia nervosa[6][9].
- Therapeutic areas
- Psychiatry
- Modalities
- Synthetic psilocybin (COMP360)[4][5]Psychedelic compounds[3]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
HealthPort collaboration to explore delivery models for underserved communities[7].Academic partnerships with scientists such as Jason Wallach, Hamilton Morris, Adam Halberstadt on novel psychedelic drug development[3].
04
Financials
- Market cap
- $1.1B
- Total revenue
- $0
- Enterprise value
- $717M
Beyond the preview
Go deeper on COMPASS Pathways.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on COMPASS Pathways.